- ATX Therapeutics launches to create evidence-based digital therapeutic products to address specific chronic health conditions and associated risk behaviors
- ATX Therapeutics is founded by CEO Adam Falat, who previously led award-winning consumer digital health teams at Walgreens and athenahealth.
Former Walgreens executive Adam Falat today announced the launch of his new Austin-TX-based digital health company, ATX Therapeutics. The new company will create evidence-based digital
Read More
Diabetes| Type 1 & 2 Diabetes Management | Policy, News, Analysis, Insights - HIT Consultant
Drugmaker Bayer to License One Drop’s Digital Diabetes Management Platform, Leads $40M Series B Funding
- Drugmaker Bayer leads One Drop’s $40M Series B funding round and enters commercial agreement to license One Drop's digital diabetes management platform in its global bio-digital efforts in therapeutic areas. - Bayer will leverage One Drop's data science and predictive capabilities, and harness its mobile platform to deliver innovative bio-digital solutions across a broad array of therapeutic areas.- One Drop provides personalized health programs to drive sustainable behavior change as part of
Read More
Abbott and Sanofi Partner to Integrate Glucose Sensing and Insulin Data
- Abbott (ABT) and Sanofi partner to integrate to developing tools that combine the FreeStyle Libre technology with Sanofi′s insulin dosing information for future smartpens, insulin titration apps and cloud software. - The integration will enable both people with diabetes and their doctors to make better-informed treatment decisions around medication, nutrition, and lifestyle.Abbott (ABT) and Sanofi, today announced they are partnering to integrate glucose sensing and insulin delivery
Read More
Novo Nordisk Integrates Smart Insulin Pens With Medtronic Continuous Glucose Monitoring (CGM) Devices
- Medtronic and Novo Nordisk to develop solutions enabling dosing data from Novo Nordisk Smart Insulin Pens to be shared with Medtronic continuous glucose monitoring devices. - Non-exclusive integration collaboration reflects both companies′commitment to making diabetes management easier by integrating key health technologies. - Novo Nordisk expects to launch its durable smart insulin pens, NovoPen® 6 and NovoPen Echo® Plus, as well as its disposable, pre-filled injection solution starting in
Read More
Healthy.io Nabs $60M for FDA-cleared Smartphone-Based Urinalysis for Chronic Kidney Disease
- Healthy.io raises $60M led by Corner Ventures for its FDA 510(k) cleared smartphone-based ACR test to be used in the aid of diagnosing chronic kidney disease (CKD).
- The funding round will be used to accelerate Healthy.io’s global expansion and product development.
- Healthy.io’s solution allows immediate electronic medical record (EMR) connectivity through the automated smartphone scan.
Healthy.io, the fast-growing Israeli digital health company that has turned
the
Read More
OnlyBoth Launches Benchmarking Engines for Comparative Analysis of Population Health Measures by City Neighborhoods
- OnlyBoth launches benchmarking engines, Benchmine for comparative analytics and reporting of population health measures in city neighborhoods.
- Benchmine.com, OnlyBoth’s benchmarking engine, can evaluate U.S. city neighborhoods based on behavioral risk factors, health outcomes, and preventive services for improved community engagement.
- To generate comparative insights, OnlyBoth uses source data from the CDC's 500 Cities: Local Data for Better Health, a project that targets 27
Read More
4 Areas Where Big Data is Transforming Healthcare Right Now
Leveraging technology in the right ways can make or break the future of healthcare. One of the ways that healthcare will become more efficient, more affordable, and save more lives is through the use of big data.
What is Big Data?
Big data refers to a large amount of information being digitized, consolidated, standardized, analyzed and modeled. In healthcare, big data uses specific statistics from a population or an individual to research new advancements, reduce costs, and even cure or prevent
Read More
Livongo’s Q2’19 Revenue Reaches $41M, Up 156% Y-o-Y
- Livongo reports Q2 19 total revenue of $40.9 million, up 156% year-over-year- 192,934 enrolled Livongo for Diabetes Members, up 140% year-over-year with 38,170 new Livongo for Diabetes Members in Q2- Total Contract Value of $74.2 million, up from $24.8 million in the second quarter of 2018. Livongo Health, Inc. (NASDAQ: LVGO), an Applied Health Signals company empowering people with chronic conditions to live better and healthier lives, today announced financial results for its second quarter
Read More
OptimizeRx Acquires Digital Therapeutics Platform RMDY Health for $16M
- OptimizeRX acquires RMDY Health, a multipurpose digital therapeutics SaaS platform, for $16 million in cash and equity.
- Acquisition will enhance OptimizeRx existing digital platform with technology solutions tailored for digital therapeutics and extends offerings to SaaS-based patient engagement markets.
- RMDY will maintain its technology team in Tel Aviv, Israel, and U.S. based personnel and use the OptimizeRx New Jersey HQ.
OptimizeRx announced it will acquire RMDY
Read More
iRhythm, Verily Collaborate to Develop Atrial Fibrillation Detection Solution
- iRhythm and Verily collaborate to develop health management solutions for atrial fibrillation patients.- The iRhythm and Verily collaboration aims to address this underserved population at risk for asymptomatic or silent AFib.- iRhythm will make an upfront payment to Verily of $5 million and potential milestone payments of up to $12.75 million.iRhythm Technologies, Inc. is teaming up with Verily, an Alphabet company focused on the development of digital health solutions aimed at improving the
Read More
